Lattanze Ronald K, Osman Medhat M, Ryan Kelley A, Frye Sarah, Townsend David W
Lucerno Dynamics, LLC, Cary, NC, United States.
Division of Nuclear Medicine, Department of Radiology, Saint Louis University, St. Louis, MO, United States.
Front Med (Lausanne). 2018 Nov 1;5:303. doi: 10.3389/fmed.2018.00303. eCollection 2018.
Infiltrations of 18F-fluorodeoxyglucose (FDG) injections affect positron emission tomography/computed tomography (PET/CT) image quality and quantification. A device using scintillation sensors (Lucerno Dynamics, Cary, NC) provides dynamic measurements acquired during FDG uptake to identify and characterize radioactivity near the injection site prior to patient imaging. Our aim was to compare sensor measurements against dynamic PET image acquisition, our proposed reference in assessing injection quality during the uptake period. Subjects undergoing routine FDG PET/CT imaging were eligible for this Institutional Review Board approved prospective study. After providing informed consent, subjects had sensors topically placed on their arms. FDG was injected into subjects' veins directly on the PET imaging table. Dynamic images of the injection site were acquired during 45 min of the uptake period. These dynamic image acquisitions and subjects' routine standard static images were evaluated by nuclear medicine physicians for abnormal FDG accumulation near the injection site. Sensor measurements were interpreted independently by Lucerno staff. Dynamic image acquisition interpretation results were compared to the sensor measurement interpretations and to static image interpretations. Twenty-four subjects were consented and enrolled. Data from 21 subjects were gathered. During dynamic image acquisition review, physicians interpreted 4 subjects with no FDG accumulation at the injection site, whereas 17 showed evidence of accumulation. In 10 of the 17 cases that showed FDG accumulation, the FDG presence at the injection site resolved completely during uptake corresponding to venous stasis, the temporary sequestration of blood from circulation. Static image interpretation agreed with dynamic images interpretation in 11/21 (52%) subjects. Sensor measurement interpretations agreed with the dynamic images interpretations in 18/21 (86%) subjects. Sensor measurements can be an effective way to identify and characterize infiltrations and venous stasis. Comparable to an infiltration, venous stasis may produce spurious and clinically meaningful measurement bias and possibly even scan misinterpretation. Since the quality and quantification of PET/CT studies are of clinical importance, sensor measurements acquired during the FDG uptake may prove to be a useful quality control measure to reduce infiltration rates and potentially improve patient care. Clinicaltrials.gov, Identifier: NCT03041090.
18F-氟脱氧葡萄糖(FDG)注射的渗漏会影响正电子发射断层扫描/计算机断层扫描(PET/CT)的图像质量和定量分析。一种使用闪烁传感器的设备(Lucerno Dynamics,北卡罗来纳州卡里)可在FDG摄取期间进行动态测量,以便在患者成像前识别并表征注射部位附近的放射性。我们的目的是将传感器测量结果与动态PET图像采集进行比较,动态PET图像采集是我们在评估摄取期注射质量时提出的参考标准。接受常规FDG PET/CT成像的受试者符合本机构审查委员会批准的前瞻性研究条件。在获得知情同意后,将传感器局部放置在受试者的手臂上。在PET成像台上直接将FDG注入受试者的静脉。在摄取期的45分钟内采集注射部位的动态图像。核医学医生对这些动态图像采集以及受试者的常规标准静态图像进行评估,以确定注射部位附近是否存在异常的FDG积聚。传感器测量结果由Lucerno工作人员独立解读。将动态图像采集的解读结果与传感器测量的解读结果以及静态图像的解读结果进行比较。24名受试者同意并参与研究。收集到了21名受试者的数据。在动态图像采集评估过程中,医生将4名受试者解读为注射部位无FDG积聚,而17名受试者显示有积聚迹象。在显示有FDG积聚的17例病例中,有10例在摄取期对应于静脉淤滞(血液从循环中暂时隔离)时,注射部位的FDG存在完全消退。静态图像解读与动态图像解读在11/21(52%)的受试者中一致。传感器测量解读与动态图像解读在18/21(86%)的受试者中一致。传感器测量可以是识别和表征渗漏及静脉淤滞的有效方法。与渗漏类似,静脉淤滞可能会产生虚假的且具有临床意义的测量偏差,甚至可能导致扫描解读错误。由于PET/CT研究的质量和定量分析具有临床重要性,在FDG摄取期间进行的传感器测量可能被证明是一种有用的质量控制措施,可降低渗漏率并潜在地改善患者护理。Clinicaltrials.gov标识符:NCT03041090。